Company Name, Ticker, Industry, else..

Integrated Biopharma Inc (INBP)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Earnings propelled by $1.09 millions tax benefit

A $1.09 millions in income tax benefit, supported Integrated Biopharma Inc to post $0.05 eps in the most recent fiscal period

Published 2022-09-14T20:17:13+00:00
Goran Soko / CSIMarket.com Contributer

Revenue demise of -22.224 % caused slump in income by -67.04 % for the fiscal fourth quarter of 2022. The company posted recent numbers of $13.27 millions in Revenue this compares to $17.06 millions a year prior and eps of $0.05 per share in proportion to 0.14 in the prior year.

In contrast to the Q3 Revenues fell by -15.14 % from $15.63 millions and EPS soared by 56.22 % from $0.03 per share.

Earnings of $1.494 millions in the financial span ending June 30 2022 fell by -66.85 % from $4.507 millions in the corresponding period a year before.

Analyzing further the financial results, the situation for Integrated Biopharma Inc is even more complicated, if there wasn't $1.09 million income tax benefit, to slow down the decline to just -66.85 % in the financial span ending June 30 2022. Looking further into financial span ending June 30 2022 Integrated Biopharma Inc's profitability, operating margin mitigated to 3.3%, and net margin shrank to 11.26%.
Operating earnings, fell -66.62% to $0.438 millions, squeezing Integrated Biopharma Inc's operating margin to %. Analyzing further the financial results for the fiscal year 2021, INBP announced Revenues of $63.56 millions and net profits of $8.01 millions.

Major Pharmaceutical Preparations company voiced as well, that Eps soared by 92.31 % to $0.25 per share from $0.13 in the prior fiscal year , and contributedRevenues improved by 20.45 % from $52.77 millions a year prior.

Integrated Biopharma Inc is expected to report next financial recent numbers on May 11, 2023.

Recently Reported Results

8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Motorsport Games Inc

Concentrating on the fourth quarter of 2022 the Software & Programming company Diminishing Returns have expanded at $-0.42 per share, relative to the results of $1.12 per share a year before quarter, In the preceding quarter the Motorsport Games Inc realized $-7.29 per share.

Motorsport Games Inc Customers

Motorsport Games Inc Revenue improvement Rates

$gasstation_[[User{1}{{{1}}}]]_at_the_English_language_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons$ Consumer Price Index

Inflation on the rise again in January 2023

U.S. Consumer prices rose again after dipping in the last month, led by increase in gasoline prices.

Father_and_son_surf_lesson_By_Mike_Baird_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Utg Inc

Impressive 215.066%, improvement in Revenues , by Utg Inc in the fourth quarter of 2022

Utg Inc has grown rapidly its recent numbers in the fourth quarter of 2022 in proportion to comparable reporting period a year prior, net profit per share soared by 557.53 % to $5.62 and Revenue soared by 215.066 % to $28.79 millions.

Utg Inc Suppliers

Utg Inc elevation Rates, Profitability, PE

New_York_Times_crosswords_By_D.L.__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Scholastic Corporation

Revenues receded by -5.689 %, at SCHL during the financial period closing Feb 28 2023

For the financial interval ending February 28 2023 SCHL increased a shortfall per share of $-0.57 per share compare to $-0.44 a year before and EPS fell from $2.12 per share from the preceding reporting season.

Revenues depreciated by -5.689 % to $324.90 millions from $344.50 millions in the same reporting season a year before and sequentially Revenue Tumbled by -44.735 % from $587.90 millions.

Scholastic Corporation Customers

Scholastic Corporation growth Rates, Profitability, PE

Cis_di_nola_By_Alcott1953_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common

Guess Inc

A sharpe Deterioration -9.735 %, in Revenues at GES during the fourth quarter of 2022 earnings season

GES disclosed earnings per share gain of 34.32 % to $1.40 on dwindling Revenue of -9.735 % to $722.07 millions in the Jan 28 2023 report, year on year.

Guess Inc Suppliers

Employment Report

Economy gains 223,000 jobs, unemployment rate 3.5 %

The nonfarm payrolls grew 223,000 in December, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,

Producer Price Index

Inflation higher in December 2022

Prices increased on the faster pace again, adding to inflationary worries.

Housing Starts

interior_Joe_Mabel_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

Security Federal Corporation

Compelling Revenues by SFDL all along the October to December 31 2022 interval

Underlining the fiscal interval ending December 31 2022 profits jumped by 62.16 % to $1.01 per share, followed by Revenue boost of 14.164 % to $13.11 millions, compared with the prior year period.

Security Federal Corporation stock quotes, charts, profile

Security Federal Corporation Revenue advance Rates

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons

Aptose Biosciences Inc

The Biotechnology & Pharmaceuticals company disclosed operating loss in the fourth quarter of 2022

While the October to December 31 2022 reporting cycle continues, the most entities have disclosed their results. In the thick of it, are several companies in the Biotechnology & Pharmaceuticals industry. As well as, now, Aptose Biosciences Inc announced operating loss of $-10.403 millions, for the fourth quarter of 2022 earnings season.

Aptose Biosciences Inc Customers

Aptose Biosciences Inc Suppliers

Inside_a_computer_By_nrkbeta_(originally_posted_to_Flickr_as_Maskinvare)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common

Meta Materials Inc

The Semiconductors company disclosed that it has experienced notable headwinds, over the fiscal three months closing Dec 31 2022

For the October to December 31 2022 span company decreased a loss per share of $-0.03 per share compare to $-0.22 a year prior and EPS improved from $-0.07 per share from the prior reporting period.

Revenues faded by -49.855 % to $1.45 millions from $2.88 millions in the similar reporting period a year prior and sequentially Revenue Tumbled by -41.135 % from $2.46 millions.

Meta Materials Inc Customers

Meta Materials Inc Income Statement, Balance sheets, Cash Flow Statement

Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common

Aslan Pharmaceuticals Limited

Aslan Pharmaceuticals Limited declared operating deficit in the fourth quarter of 2022

The investors have not anticipated some moderations at the revenue during the the October to December 31 2022 reporting season at the Aslan Pharmaceuticals Limited. However, they monitor the Biotechnology & Pharmaceuticals company's operating deficit which was at $-47.882487 millions, in the same period.

Aslan Pharmaceuticals Limited Suppliers

Aslan Pharmaceuticals Limited growth Rates, Profitability, PE

Credit-cards_By_Lotus_Head_from_Johannesburg,_Gauteng,_South_Africa_(sxc.hu)__(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons

First Seacoast Bancorp Inc

Very pressing quarter at FSEA over the financial span closing Dec 31 2022

For the financial period ending December 31 2022 FSEA slipped into loss of $-0.28 per share compare to $0.07 a year prior and EPS fell from $0.08 per share from the prior reporting period.

Revenues decreased considerably by -13.143 % to $3.23 millions from $3.71 millions in the similar reporting period a year prior and sequentially Revenues fell by -23.488 % from $4.22 millions.

First Seacoast Bancorp Inc Customers

First Seacoast Bancorp Inc Revenue growth Rates

Justine_Ezarik_By_Brian_Solis__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common

Pldt Inc

The Communications Services company recorded mixed numbers in the fourth quarter of 2022, where Revenue rose by 6.203 % to $3.92 billions compared to $3.70 billions on a year-over-year basis, while income per share dived by -60.36 % to $0.92 per share, off $2.33 in the prior year reporting period.

Pldt Inc stock quotes, charts, profile

Pldt Inc Suppliers

Other INBP's Earnings Reports

Integrated Biopharma Inc reported third quarter 2022 earnings

Integrated Biopharma Inc reported second quarter 2022 earnings

Integrated Biopharma Inc reported first quarter 2022 earnings


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar ACN's Profile Stock Price ACN's Financials Business Description Fundamentals Charts & Quotes ACN's News Suppliers ACN's Competitors Customers & Markets Economic Indicators ACN's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071